Evidence map›Paper›PMID 32910291›Full record

ArticleEJNMMI research2020

The feasibility of [

Maren Laasik, Johanna Hynninen, Sarita Forsback, Tommi Noponen, Marko Seppänen, Sakari Hietanen

Open access · goldAbstract read
In one paragraph

Article in EJNMMI research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.3field-weighted citation impact, top 49% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Maren LaasikDepartment of Obstetrics and Gynecology, Turku University Hospital, Turku, Finland.
Johanna HynninenDepartment of Obstetrics and Gynecology, Turku University Hospital, Turku, Finland.
Sarita ForsbackDepartment of Chemistry, Turku PET Centre, University of Turku, Turku, Finland.
Tommi NoponenDepartment of Nuclear Medicine, Turku PET Centre, University of Turku, Turku, Finland.
Marko SeppänenDepartment of Nuclear Medicine, Turku PET Centre, University of Turku, Turku, Finland.
Sakari HietanenDepartment of Obstetrics and Gynecology, Turku University Hospital, Turku, Finland. sakari.hietanen@utu.fi.ORCID http://orcid.org/0000-0003-4734-4743
Turku University Hospital · FIUniversity of Turku · FI

Funding

Horizon 2020 667403
6 · The paper itself

Abstract

rationaleEvaluation of the feasibility of [

methodsFifteen patients with a suspected malignant ovarian tumor were scanned with [

results[

conclusions[

Indexed as

EF5-PET/CTHypoxiaOvarian cancer

Identifiers

PMID32910291
PMCPMC7483702
OpenAlexW3085249010

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.